Cortexyme (CRTX) stock forecast for 2024. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Cortexyme (CRTX) stock forecast for 2024

Updated: March 28, 2024 (06:50)

Sector: Healthcare

The share price of Cortexyme, Inc. (CRTX) now

What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Cortexyme stocks, the 50-day moving average is the support level today.

For Cortexyme stocks, the 200-day moving average is the support level today.

Are you interested in Cortexyme, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Cortexyme stock price in 2024. How much will one Cortexyme share be worth in 2024? Is it worth taking profit / loss on CRTX stock now or waiting? What are analysts' forecasts for Cortexyme stock?

We forecast Cortexyme stock performance using neural networks based on historical data on CRTX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Cortexyme, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Cortexyme analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).




Historical and forecast chart of Cortexyme, Inc. stock

The chart below shows the historical price of Cortexyme stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRTX stock price can be found in the table below.


Cortexyme, Inc., a clinical stage biopharmaceutical company, specializes in the development of therapeutics for the treatment of Alzheimer’s disease and other degenerative diseases. Its main drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule inhibitor of gingipain, which is in phase II/III clinical trials for use in patients with mild to moderate Alzheimer’s disease. Cortexyme Inc. is a partner of the Parkinson Study Group.

Cortexyme (CRTX) Forecast for 2024

Month Target Pes. Opt. Vol., %
Apr 1.12 0.96 1.27 23.81 %
May 1.08 0.98 1.22 20.14 %
Jun 1.12 1.02 1.26 19.29 %
Jul 1.01 0.87 1.14 24.25 %
Aug 1.03 0.95 1.16 18.23 %
Sep 0.96 0.87 1.06 18.41 %
Oct 1.02 0.96 1.18 19.06 %
Nov 0.92 0.86 0.96 10.00 %
Dec 0.99 0.87 1.09 20.18 %

Cortexyme information and performance

Cortexyme Address

N/A

Market Capitalization: N/A $

Market capitalization of the Cortexyme, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRTX shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Cortexyme is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Cortexyme price target for 2024 by month


Target values for the price of one Cortexyme share for Apr 2024.

The weighted average target price per Cortexyme share in Apr 2024 is: 1.12.
In Apr, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 23.809% volatility is expected.
Pessimistic target level: 0.96
Optimistic target level: 1.27

Target values for the price of one Cortexyme share for May 2024.

The weighted average target price per Cortexyme share in May 2024 is: 1.08.
In May, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 20.141% volatility is expected.
Pessimistic target level: 0.98
Optimistic target level: 1.22

Target values for the price of one Cortexyme share for Jun 2024.

The weighted average target price per Cortexyme share in Jun 2024 is: 1.12.
In Jun, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 19.292% volatility is expected.
Pessimistic target level: 1.02
Optimistic target level: 1.26

Target values for the price of one Cortexyme share for Jul 2024.

The weighted average target price per Cortexyme share in Jul 2024 is: 1.01.
In Jul, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 24.253% volatility is expected.
Pessimistic target level: 0.87
Optimistic target level: 1.14

Target values for the price of one Cortexyme share for Aug 2024.

The weighted average target price per Cortexyme share in Aug 2024 is: 1.03.
In Aug, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 18.230% volatility is expected.
Pessimistic target level: 0.95
Optimistic target level: 1.16

Target values for the price of one Cortexyme share for Sep 2024.

The weighted average target price per Cortexyme share in Sep 2024 is: 0.96.
In Sep, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 18.411% volatility is expected.
Pessimistic target level: 0.87
Optimistic target level: 1.06

Target values for the price of one Cortexyme share for Oct 2024.

The weighted average target price per Cortexyme share in Oct 2024 is: 1.02.
In Oct, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 19.064% volatility is expected.
Pessimistic target level: 0.96
Optimistic target level: 1.18

Target values for the price of one Cortexyme share for Nov 2024.

The weighted average target price per Cortexyme share in Nov 2024 is: 0.92.
In Nov, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 10.000% volatility is expected.
Pessimistic target level: 0.86
Optimistic target level: 0.96

Target values for the price of one Cortexyme share for Dec 2024.

The weighted average target price per Cortexyme share in Dec 2024 is: 0.99.
In Dec, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 20.182% volatility is expected.
Pessimistic target level: 0.87
Optimistic target level: 1.09



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.